Leading the Way in Life Science Technologies

GEN Exclusives

More »

January 15, Vol. 32, No. 2

  • Columns

    • Declaration of Independence
    • Adelene Q. Perkins
    • The start of a new year is usually accompanied by lively speculation about the hottest biotech acquisition candidates in the coming months, and I’m sure this year will be no exception Confronted with looming patent expirations, the fading blockbuster model, ... more »
    • Serum Focus Gives Way to Complete Systems
    • Carol Potera
    • Thermo Electron and Fisher Scientific merged and formed Thermo Fisher Scientific in 2006 Among Fisher’s product lines at the time of the acquisition was HyClone, a manufacturer of sera, dry powdered media, liquid media, and disposable BioProcess Containers (BPC) for ... more »
    • Shopping for Financing “At-the-Market”
    • Todd Wyche
    • Publicly traded life science companies are constantly searching for new sources of capital to fund their activities Companies generally follow a traditional approach employing conventional financing vehicles such as secondary offerings, registered directs, and private investments in public equities (PIPEs)... more »
    • Tools and Technologies to Advance Cell Biology E...
    • Vicki Glaser
    • EMD Millipore (a division of Merck KGaA) introduced the Muse™ cell-analysis platform at the American Society for Cell Biology annual conference The Muse provides multiparametric information on cell populations for real-time quantitative assessment of cell concentration, cell health, apoptosis, and ... more »